CCNA2 and lung cancer: We then carried out transcriptional transactivation assays as shown in Fig. 5a, using the cyclin A2 and Chk1 promoters driving luciferase expression (CCNA2-luc and Chk1-luc) as reporter constructs in p53-null H1299 lung cancer cells.